Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manh-Cuong Vo

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Critical Reviews in Oncology/Hematology|March 6, 2017
Immunotherapy for the treatment of multiple myelomaSung-Hoon Jung, Hyun-Ju Lee, Manh-Cuong Vo, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 13, 2014
Generation of multiple peptide cocktail-pulsed dendritic cells as a cancer vaccineHyun-Ju Lee, Nu-Ri Choi, Manh-Cuong Vo, et al.
Cancer Immunology, Immunotherapy : CII|July 6, 2020
Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myelomaTan-Huy Chu, Manh-Cuong Vo, Hye-Seong Park, et al.
Sensors (Basel, Switzerland)|January 30, 2021
Pilot Study: Quantitative Photoacoustic Evaluation of Peripheral Vascular Dynamics Induced by Carfilzomib In VivoThi Thao Mai, Manh-Cuong Vo, Tan-Huy Chu, et al.
Experimental & Molecular Medicine|August 20, 2016
Sarcoplasmic reticulum Ca(2+) ATPase 2 (SERCA2) reduces the migratory capacity of CCL21-treated monocyte-derived dendritic cellsCheol Yi Hong, Hyun-Ju Lee, Nu-Ri Choi, et al.
Oncotarget|May 3, 2017
Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer modelManh-Cuong Vo, Thanh-Nhan Nguyen-Pham, Hyun-Ju Lee, et al.
Journal of Hematology & Oncology|October 28, 2025
Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?Manh-Cuong Vo, Van-Dinh-Huan Tran, Van-Tan Nguyen, et al.
Cytotherapy|July 28, 2015
Generation of potent dendritic cells with improved migration ability through p-cofilin and sarco/endoplasmic reticulum Ca(2+) transport ATPase 2 regulationNu-Ri Choi, Hyun-Ju Lee, Sung-Hoon Jung, et al.
Experimental Hematology|November 28, 2016
Lenalidomide enhances the function of dendritic cells generated from patients with multiple myelomaManh-Cuong Vo, Truc Anh-NguyenThi, Hyun-Ju Lee, et al.
Frontiers in Oncology|November 29, 2023
Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma TreatmentSon Hai Vu, Ha Hong Pham, Thao Thi Phuong Pham, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Critical Reviews in Oncology/Hematology|March 6, 2017
Immunotherapy for the treatment of multiple myelomaSung-Hoon Jung, Hyun-Ju Lee, Manh-Cuong Vo, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 13, 2014
Generation of multiple peptide cocktail-pulsed dendritic cells as a cancer vaccineHyun-Ju Lee, Nu-Ri Choi, Manh-Cuong Vo, et al.
Cancer Immunology, Immunotherapy : CII|July 6, 2020
Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myelomaTan-Huy Chu, Manh-Cuong Vo, Hye-Seong Park, et al.
Sensors (Basel, Switzerland)|January 30, 2021
Pilot Study: Quantitative Photoacoustic Evaluation of Peripheral Vascular Dynamics Induced by Carfilzomib In VivoThi Thao Mai, Manh-Cuong Vo, Tan-Huy Chu, et al.
Experimental & Molecular Medicine|August 20, 2016
Sarcoplasmic reticulum Ca(2+) ATPase 2 (SERCA2) reduces the migratory capacity of CCL21-treated monocyte-derived dendritic cellsCheol Yi Hong, Hyun-Ju Lee, Nu-Ri Choi, et al.
Oncotarget|May 3, 2017
Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer modelManh-Cuong Vo, Thanh-Nhan Nguyen-Pham, Hyun-Ju Lee, et al.
Journal of Hematology & Oncology|October 28, 2025
Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?Manh-Cuong Vo, Van-Dinh-Huan Tran, Van-Tan Nguyen, et al.
Cytotherapy|July 28, 2015
Generation of potent dendritic cells with improved migration ability through p-cofilin and sarco/endoplasmic reticulum Ca(2+) transport ATPase 2 regulationNu-Ri Choi, Hyun-Ju Lee, Sung-Hoon Jung, et al.
Experimental Hematology|November 28, 2016
Lenalidomide enhances the function of dendritic cells generated from patients with multiple myelomaManh-Cuong Vo, Truc Anh-NguyenThi, Hyun-Ju Lee, et al.
Frontiers in Oncology|November 29, 2023
Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma TreatmentSon Hai Vu, Ha Hong Pham, Thao Thi Phuong Pham, et al.
Pageof 4